Mon, July 26, 2021
Fri, July 23, 2021
Thu, July 22, 2021
Wed, July 21, 2021
Tue, July 20, 2021
Mon, July 19, 2021
Fri, July 16, 2021
Thu, July 15, 2021

Tazeen Ahmad Maintained (ACAD) at Hold with Increased Target to $26 on, Jul 21st, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-26-on-jul-21st-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Tazeen Ahmad of B of A Securities, Maintained "ACADIA Pharmaceuticals Inc." (ACAD) at Hold with Increased Target from $24 to $26 on, Jul 21st, 2021.

Tazeen has made no other calls on ACAD in the last 4 months.



There are 8 other peers that have a rating on ACAD. Out of the 8 peers that are also analyzing ACAD, 6 agree with Tazeen's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Esther Hong of "Berenberg" Initiated at Hold and Held Target at $29 on, Thursday, June 10th, 2021
  • Sumant Kulkarni of "Canaccord Genuity" Maintained at Hold with Increased Target to $27 on, Wednesday, May 12th, 2021
  • Andrew Fein of "HC Wainwright & Co." Downgraded from Strong Buy to Hold and Decreased Target to $18 on, Wednesday, April 7th, 2021
  • Chris Howerton of "Jefferies" Downgraded from Strong Buy to Hold and Decreased Target to $21 on, Tuesday, April 6th, 2021
  • Vamil Divan of "Mizuho" Downgraded from Strong Buy to Hold and Held Target at $25 on, Tuesday, April 6th, 2021
  • Salveen Richter of "Goldman Sachs" Downgraded from Strong Buy to Hold and Decreased Target to $25 on, Tuesday, April 6th, 2021


These are the ratings of the 2 analyists that currently disagree with Tazeen


  • Jeffrey Hung of "Morgan Stanley" Maintained at Buy with Increased Target to $29 on, Thursday, May 6th, 2021
  • Joseph Stringer of "Needham" Maintained at Strong Buy with Decreased Target to $30 on, Monday, April 5th, 2021

Publication Contributing Sources